Asia-Pacific Society for Patient Blood Management

> ASPBM > Overview


It’s time to introduce a new paradigm
for the 21st century medical community.

Welcome to the ASPBM, Asia-Pacific Society for Patient Blood Management.

Our Purpose
- Minimize complications of blood and blood products
- Manage inadequate blood supply
- Protect patients’ rights to refrain from the use of allogeneic blood on medical or religious grounds

Since World War I, modern day medical standards have centered on ‘allogeneic transfusion.’ Blood is a liquid organ and as such transfusion therapy is in effect an organ transplant. However, the effects or adverse response to transfusion has not been clearly documented, as compared with numerous studies on other transplantation.

In addition, up until recent years, a hemoglobin level below 10g/dl was the trigger indicating the need for transfusion. This level was first suggested by Adams and Lundy’s obstetrics and gynecology study some 65 years ago. Despite significant developments in the medical community, many doctors still depend upon this age old study. The age of the study suggests that insufficient research has been done to confirm this transfusion trigger.

It has been reported that 66% of clinically implemented transfusions are unnecessary. Although the allogeneic transfusion is the simplest option to increase hemoglobin count, it may have many side effects, and at times can be fatal.

More advanced blood screening has been used to secure safe transfusion, as strict donor qualifications have been applied. However, since the trend in society where people no longer care for others is becoming more prevalent, it is becoming difficult to supply blood nationwide. Also many reports of the side effects of blood transfusion cause patients to avoid blood transfusion as much as possible.

Therefore this Society is established to research various clinical strategies to reduce the use of allogeneic transfusion to a minimum or completely replace it, if possible, to establish a standard of care for the alternatives to blood transfusions according to the society’s current needs, and to promote that standard of care to achieve better results for patients.

It’s time to introduce a new paradigm for the 21st century medical community.
Copyright ⓒ ASPBM. All rights reserved.